Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1995 2
1996 2
1997 1
1999 1
2000 1
2002 2
2003 1
2004 2
2005 4
2006 2
2007 1
2008 1
2009 3
2010 4
2011 3
2012 6
2013 3
2014 1
2015 4
2016 3
2017 2
2018 3
2019 1
2020 6
2021 5
2022 11
2023 4

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
Management of Peripheral Arthritis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations.
Leung YY, Korotaeva TV, Candia L, Pedersen SJ, Bautista Molano W, Ruderman EM, Bisoendial R, Perez-Alamino R, Olsder W, Möller B, Grazio S, Gudu T, Mody GM, Pineda C, Raffayova H, Rohekar S, Goldenstein-Schainberg C, Gutierrez Urena SR, Casasola Vargas JC, Meghnathi B, Prasad R, Richette P, Miranda JRS, Malliotis N, Lindqvist U, Simon D, Ezeonyeji A, Soriano ER, FitzGerald O. Leung YY, et al. Among authors: ruderman em. J Rheumatol. 2023 Jan;50(1):119-130. doi: 10.3899/jrheum.220315. Epub 2022 Oct 15. J Rheumatol. 2023. PMID: 36243409 Free article. Review.
Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials.
Burmester GR, Winthrop K, Blanco R, Nash P, Goupille P, Azevedo VF, Salvarani C, Rubbert-Roth A, Lesser E, Lippe R, Lertratanakul A, Mccaskill RM, Liu J, Ruderman EM. Burmester GR, et al. Among authors: ruderman em. Rheumatol Ther. 2022 Apr;9(2):521-539. doi: 10.1007/s40744-021-00410-z. Epub 2021 Dec 30. Rheumatol Ther. 2022. PMID: 34970731 Free PMC article.
Learning from Adversity: Lessons from the COVID-19 Crisis.
Putman MS, Ruderman EM. Putman MS, et al. Among authors: ruderman em. J Rheumatol. 2020 Jun 1;47(6):791-792. doi: 10.3899/jrheum.200411. Epub 2020 Apr 8. J Rheumatol. 2020. PMID: 32269063 Free article. Review. No abstract available.
More than just B-cell inhibition.
Ruderman EM, Pope RM. Ruderman EM, et al. Arthritis Res Ther. 2011 Aug 30;13(4):125. doi: 10.1186/ar3439. Arthritis Res Ther. 2011. PMID: 21878134 Free PMC article.
Dr. Putman et al reply.
Putman M, Berquist JB, Ruderman EM, Sparks JA. Putman M, et al. Among authors: ruderman em. J Rheumatol. 2023 Jan;50(1):157-158. doi: 10.3899/jrheum.220735. Epub 2022 Sep 1. J Rheumatol. 2023. PMID: 36587953 No abstract available.
A Road Map of the Axial Spondyloarthritis Continuum.
Schwartzman S, Ruderman EM. Schwartzman S, et al. Among authors: ruderman em. Mayo Clin Proc. 2022 Jan;97(1):134-145. doi: 10.1016/j.mayocp.2021.08.007. Epub 2021 Nov 18. Mayo Clin Proc. 2022. PMID: 34801248 Free article. Review.
Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial.
Mease PJ, Gladman DD, Ritchlin CT, Ruderman EM, Steinfeld SD, Choy EH, Sharp JT, Ory PA, Perdok RJ, Weinberg MA; Adalimumab Effectiveness in Psoriatic Arthritis Trial Study Group. Mease PJ, et al. Among authors: ruderman em. Arthritis Rheum. 2005 Oct;52(10):3279-89. doi: 10.1002/art.21306. Arthritis Rheum. 2005. PMID: 16200601 Free article. Clinical Trial.
72 results